Virus-resistant grapevines
However, there will soon be a cure for GFLV infections: Researchers at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen are making certain plants resistant to the GFLV by genetic engineering. "Our modified plants produce antibodies," explains Dr. Stefan Schillberg, head of department at the IME. "These antibodies 'recognize' the viruses and prevent them from spreading in the plant and causing damage." To enable the plant to produce the antibodies, the scientists have to modify its genotype and channel genetic information for the antibodies into it. This task is performed by tiny helpers called agrobacteria, which genetic engineers have been using for over twenty years. These are soil bacteria that inherently transfer parts of their own genome to that of the plant. Using simple routine processes, the researchers introduce the antibody gene into the bacteria, which then act as a transport vehicle and carry it over to the vine.
The researchers are still testing this process on model plants, and the first results show that their modified versions are up to 100 percent resistant to the virus. "The antibody is produced very effectively inside the plants," says Schillberg. "The next step on the agenda is to test the method on actual grapevines and then to carry out field tests." The scientists' long-term goal is to curb the use of pesticides. "Certain pesticides are necessary to fight GFLV infections," Schillberg explains. But they often only have a limited effect. They are also harmful to the environment and therefore banned in many regions. Countries like Chile, for example, which depend strongly on their winegrowing business, could benefit enormously from the pathogen-resistant grapevines and improve their crop yields.
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous